期刊文献+

甲状腺乳头状癌中NIS基因启动子区5′-CpG岛异常甲基化状况及其意义 被引量:2

The Status of 5'-CpG Island Promoter Methylation of Sodium Iodide Symporter Gene in Papillary Thyroid Cancer and its Significance
原文传递
导出
摘要 [目的]探讨甲状腺乳头状癌(PTC)钠/碘协同转运体(Na+/I-symporter,NIS)基因启动子区5′-CpG岛异常甲基化状态及其与临床病理参数之间的关系。[方法]应用实时荧光甲基化特异性聚合酶链反应(real-timemethylation-specificPCR,qMSP)分别检测152例PTC患者癌组织及其癌旁正常组织中NIS基因启动子区域5′-CpG岛甲基化情况,并分析其与临床病理等参数之间的关系。[结果]在152例PTC组织中,NIS基因启动子区域5′-CpG岛甲基化率为30.9%(47/152),而癌旁正常组织中甲基化率为6.58%(10/152),两组比较存在显著性差异(P<0.01)。NIS基因启动子区域5′-CpG岛甲基化与肿瘤病灶数目、淋巴结转移及临床分期有关(P<0.05),与肿瘤大小、局部侵犯、性别和年龄等无关(P>0.05)。[结论]NIS基因启动子区域5′-CpG岛的异常甲基化是PTC频发的分子事件,可能是导致甲状腺细胞摄碘率下降的重要原因之一,在PTC的发生发展过程中发挥着重要作用。 [Purpose] To investigate the status of 5'-CpG island promoter methylation of sodium iodide symporter(NIS) gene in papillary thyroid cancer(PTC) and its relationship with clinical features.[Methods] The status of 5'-CpG island promoter methylation of NIS gene in cancer tissues and in cancer adjacent tissues of the 152 cases with PTC was detected by real-time methylationspecific PCR(qMSP).And the relationship between the status of NIS 5'-CpG island methylation and clinical pathological parameters was analyzed.[Results] The methylation rate of 5'-CpG island of NIS gene in cancer tissues and in cancer adjacent tissues of the 152 cases was 30.9%(47/152) and 6.58%(10/152) respectively,with significant difference(P 0.01).The 5'-CpG island promoter methylation of NIS gene in PTC was related to number of lesions,lymph node metastasis and clinical stage(P0.05),and not related to tumor size,local invasion,gender and age(P0.05).[Conclusion] 5'-CpG island promoter methylation of NIS region is a common molecular event in PTC,and it may be one of the reasons of iodine uptake rate decreasing in thyroid cells,which plays an important role in carcinogenesis of PTC.
出处 《肿瘤学杂志》 CAS 2010年第11期885-888,共4页 Journal of Chinese Oncology
基金 浙江省医药卫生科学研究基金计划(2010KYA037 2010KYA031) 浙江省卫生高层次创新人才培养工程基金
关键词 甲状腺乳头状癌 钠/碘协同转运体 甲基化 实时荧光定量甲基化-PCR papillary thyroid carcinomas Na+/I-symporter methylation real-time methylation-specific PCR
  • 相关文献

参考文献13

  • 1Handkiewicz-Junak D, Czarniecka A, Jarzab B. Molecular prognostic markers in papillary and follicular thyroid can- cer: current status and future directions [J]. Mol Cell En- doerinol, 2010, 322(1-2) :8-28.
  • 2李君,严丽萍,滕晓东.甲状腺转录因子在甲状腺良恶性病变中的表达[J].肿瘤学杂志,2003,9(1):19-20. 被引量:4
  • 3Latif R, Morshed SA, Zaidi M, et al. The thyroid-stimu- lating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor anti- bodies on multimerization, cleavage, and signaling[J]. En- docrinol Metab Clin North Am, 2009, 38(2):319-341.
  • 4Neumann S, Raaka BM, Gershengorn MC. Human TSH receptor ligands as pharmacological probes with potential clinical application [J]. Expert Rev Endocrinol Metab, 2009, 4(6):669-679.
  • 5Smith JA, Fan CY, Zou C, et al. Methylation status of genes in papillary thyroid carcinoma [J]. Arch Otolaryngol Head Neck Surg, 2007, 133(10):1006-1011.
  • 6Khoo TK, Bahn RS. Pathogenesis of Graves ophthalmopa- thy: the role of autoantibodies [J]. Thyroid, 2007, 17(10): 1013-1018.
  • 7Kursawe R, Paschke R. Modulation of NIS signaling by posttranslational modifications [J]. Trends Endocrinol Metab, 2007, 18(5):199-207.
  • 8De Smet C, Loriot A. DNA hypomethylation in cancer: epigenetic scars of a neoplastic journey [J]. Epigenetics, 2010, Apr 10.[Epub ahead of print].
  • 9Ullah MF, Aatif M. The footprints of cancer development: Cancer biomarkers[J].Cancer Treat Rev,2009,35(3):193-200.
  • 10Hoque MO, Rosenbaum E, Westra WH, et al. Quantitative assessment of promoter methylation profiles in thyroid neo- plasms [J]. J Clin Endocrinol Metab, 2005, 90 (7):4011- 4018.

二级参考文献6

  • 1[1]Bejarano PA,Baughman RP,Biddinger PW,et al.Surgactant proteins and thyroid transcription factor 1 in pulmonary and breast carcinomas[J].Mod Pathol, 1996,9445-9452.
  • 2[2]Fabio P,Fabio B,Damante G,et al. Prognostic value of thyroid transcription factor 1 in primary, resected,non small cell lung carcinoma[J].Mod Pathol, 1999,12:318-324.
  • 3[3]Bejarano PA,Niliforov YE, Swenson ES,et al.Thyroid transcription factor 1, throglobulin, cytokeratin 7,and cytokeratin 20 in thyroid neoplasms[J]. Appl Immunohistochem Mol Morphol,2000,8(3):189-194.
  • 4[4]Katoh R,Kawaoi A,Miyagi E,et al. Thyroid transcription factor 1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization[J].Mod Pathol,2000,13:570-576.
  • 5[5]Ros P,Rossi DL.Thyroid specific gene expression in the multi step process of thyroid carcinogensis[J].Biochem,1999,81:389-396.
  • 6[6]Katoh R,Miyagi E,Nakamura N,et al. Expression of thyroid transcription factor 1(TTF 1) in human C cells and medullary throid carcinomas[J]. Hum Pathol, 2000,31: 386-393.

共引文献4

同被引文献28

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部